DENTSPLY SIRONA (NASDAQ:XRAY) Announces Earnings Results

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) posted its quarterly earnings data on Thursday. The medical instruments supplier reported $0.42 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.42, RTT News reports. DENTSPLY SIRONA had a negative net margin of 3.33% and a positive return on equity of 11.14%. The company had revenue of $953.00 million for the quarter, compared to the consensus estimate of $969.45 million. During the same quarter in the previous year, the firm posted $0.39 EPS. The business's revenue was down 2.6% compared to the same quarter last year. DENTSPLY SIRONA updated its FY24 guidance to $2.00-$2.10 EPS.

DENTSPLY SIRONA Trading Down 6.0 %

NASDAQ XRAY traded down $1.80 during trading hours on Thursday, hitting $28.38. The company's stock had a trading volume of 6,400,224 shares, compared to its average volume of 3,328,855. The stock has a fifty day moving average of $32.24 and a 200 day moving average of $32.73. DENTSPLY SIRONA has a twelve month low of $26.27 and a twelve month high of $43.24. The firm has a market capitalization of $5.88 billion, a P/E ratio of -45.77, a PEG ratio of 1.21 and a beta of 1.00. The company has a quick ratio of 0.95, a current ratio of 1.38 and a debt-to-equity ratio of 0.55.

DENTSPLY SIRONA Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 12th. Investors of record on Friday, March 29th were issued a $0.16 dividend. This is a positive change from DENTSPLY SIRONA's previous quarterly dividend of $0.14. This represents a $0.64 annualized dividend and a yield of 2.26%. The ex-dividend date was Wednesday, March 27th. DENTSPLY SIRONA's dividend payout ratio is currently -103.22%.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the stock. StockNews.com raised shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research note on Friday, January 19th. Needham & Company LLC restated a "buy" rating and issued a $42.00 price target on shares of DENTSPLY SIRONA in a research report on Thursday, February 29th. Barrington Research restated an "outperform" rating and issued a $41.00 price target on shares of DENTSPLY SIRONA in a research report on Thursday, April 18th. Piper Sandler boosted their price target on shares of DENTSPLY SIRONA from $31.00 to $35.00 and gave the company a "neutral" rating in a research report on Friday, January 12th. Finally, Leerink Partnrs restated an "outperform" rating on shares of DENTSPLY SIRONA in a research report on Monday, February 26th. Three research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $39.50.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.